Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group.

por Wingren, S., Stål, O., Nordenskjöld, B.
Publicado 1994

Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer

por Lundgren, K, Nordenskjöld, B, Landberg, G
Publicado 2009

Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.

por Stål, O., Carstensen, J., Hatschek, T., Nordenskjöld, B.
Publicado 1992

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group.

por Stenmark-Askmalm, M., Stål, O., Olsen, K., Nordenskjöld, B.
Publicado 1995

DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

por Tytor, M., Franzén, G., Olofsson, J., Brunk, U., Nordenskjöld, B.
Publicado 1987

Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer

por Stal, O, Akerberg, L, Nordenskjold, B, Olsson, B, Rutqvist, LE, Skoog, L
Publicado 2000

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer

por Weiner, M., Skoog, L., Fornander, T., Nordenskjöld, B., Sgroi, D. C., Stål, O.
Publicado 2013

Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.

por Skoog, L., Ost, A., Biberfeld, P., Christensson, B., Hast, R., Lagerlöf, B., Nordenskjöld, B., Reizenstein, P.
Publicado 1984

A pilot study on risk factors and p53 gene expression in colorectal cancer.

por Fredrikson, M., Axelson, O., Sun, X. F., Arbman, G., Nilsson, E., Nordenskjöld, B., Sjödahl, R., Söderkvist, P.
Publicado 1996

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

por Stål, O., Skoog, L., Rutqvist, L. E., Carstensen, J. M., Wingren, S., Sullivan, S., Andersson, A. C., Dufmats, M., Nordenskjöld, B.
Publicado 1994

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial

por Rosell, J, Nordenskjöld, B, Bengtsson, N-O, Fornander, T, Hatschek, T, Lindman, H, Malmström, P-O, Wallgren, A, Stål, O, Carstensen, J
Publicado 2011

Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up

por Chamalidou, C., Fohlin, H., Albertsson, P., Arnesson, L.-G., Einbeigi, Z., Holmberg, E., Nordenskjöld, A., Nordenskjöld, B., Karlsson, P., Linderholm, B.
Publicado 2021

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

por Jerevall, P-L, Ma, X-J, Li, H, Salunga, R, Kesty, N C, Erlander, M G, Sgroi, D C, Holmlund, B, Skoog, L, Fornander, T, Nordenskjöld, B, Stål, O
Publicado 2011